SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-010534
Filing Date
2021-05-17
Accepted
2021-05-17 16:29:32
Documents
62
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q medavail-20210331.htm   iXBRL 10-Q 1219109
2 EX-31.1 exhibit311-10xqxq1x2021.htm EX-31.1 11357
3 EX-31.2 exhibit312-10xqxq1x2021.htm EX-31.2 11311
4 EX-32.1 exhibit321-10qxq1x2021.htm EX-32.1 8072
  Complete submission text file 0001628280-21-010534.txt   5689985

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT medavail-20210331.xsd EX-101.SCH 42446
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT medavail-20210331_cal.xml EX-101.CAL 71225
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT medavail-20210331_def.xml EX-101.DEF 123638
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT medavail-20210331_lab.xml EX-101.LAB 524818
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT medavail-20210331_pre.xml EX-101.PRE 311634
10 EXTRACTED XBRL INSTANCE DOCUMENT medavail-20210331_htm.xml XML 983764
Mailing Address 6665 MILLCREEK DR UNIT 1 MISSISSAUGA A6 L5N 5M4
Business Address 6665 MILLCREEK DR UNIT 1 MISSISSAUGA A6 L5N 5M4 973-509-0444
MedAvail Holdings, Inc. (Filer) CIK: 0001402479 (see all company filings)

IRS No.: 900772394 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36533 | Film No.: 21931269
SIC: 2834 Pharmaceutical Preparations